Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Pharmaceutical Journal is Scopus-indexed (Q4, CiteScore 0.6), DOAJ. Published by Sciendo.
Checked against the index lists dated .
ISSN 2453-6725Verify ISSN ↗
Publisher: Sciendo
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 69 / 79 | 13th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q4, CiteScore 0.6.
European Pharmaceutical Journal is Q4 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 69 of 79), by CiteScore 2025.
European Pharmaceutical Journal is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.6, quartile Q4, 13th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.149, quartile Q4, with an H-index of 11.
European Pharmaceutical Journal is published by Sciendo. Its ISSN is 2453-6725.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
European Pharmaceutical Journal has an h-index of 9 and a 2-year mean of 0.35 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #61 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
European Pharmaceutical Journal published 13 papers in 2025; its busiest recent year was 2021 with 27. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 86 research articles (2021–2026), authors are most often from Slovakia (60.5%), Czechia (6.4%) and Indonesia (5.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (3.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.